Farah Nabil, & Saleem, M. (2026). First-Line FOLFIRINOX vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort. Middle Eastern Cancer and Oncology Journal, 2(2), 11-17. https://doi.org/10.61706/MECOJ160191